Literature DB >> 3374769

High affinity binding of [3H] (-)-nicotine to rat brain membranes and its inhibition by analogues of nicotine.

C Reavill1, P Jenner, R Kumar, I P Stolerman.   

Abstract

Analysis of the characteristics of cerebral binding of [3H] (-)-nicotine revealed a single population of sites with high affinity (KD = 6.0 +/- 0.6 nM). The regional distribution of the binding of [3H] (-)-nicotine was heterogeneous with the largest concentration of binding sites being in the thalamus, cortex and striatum, and a low level of binding activity in the cerebellum and hypothalamus. Competition studies showed that several metabolites and congeners of nicotine potently competed with [3H] (-)-nicotine and their in vitro activity was correlated with behavioural activity, as estimated from previously published data for rats trained to discriminate central effects of nicotine. Conversely, nicotine antagonists, with the exception of dihydro-beta-erythroidine, were weak or inactive in this binding assay. It is concluded that the binding site for [3H] (-)-nicotine investigated probably mediates at least one of the behavioural effects of nicotine, the nicotine discrimative stimulus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3374769     DOI: 10.1016/0028-3908(88)90039-1

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  18 in total

1.  The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists.

Authors:  J Auta; P Longone; A Guidotti; E Costa
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

2.  A general procedure for the enantioselective synthesis of the minor tobacco alkaloids nornicotine, anabasine, and anatabine.

Authors:  Joshua T Ayers; Rui Xu; Linda P Dwoskin; Peter A Crooks
Journal:  AAPS J       Date:  2005-10-31       Impact factor: 4.009

3.  Influence of experimental history on nicotine self-administration in squirrel monkeys.

Authors:  Rajeev I Desai; Katherine A Sullivan; Stephen J Kohut; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-04-04       Impact factor: 4.530

4.  Nicotinic effects of tobacco smoke constituents in nonhuman primates.

Authors:  Rajeev I Desai; Michelle R Doyle; Sarah L Withey; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-02-19       Impact factor: 4.530

5.  Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist.

Authors:  M I Damaj; K R Creasy; S P Welch; J A Rosecrans; M D Aceto; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

6.  A comparison of the binding of nicotine and nornicotine stereoisomers to nicotinic binding sites in rat brain cortex.

Authors:  J R Copeland; A Adem; P Jacob; A Nordberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

7.  Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Pflugers Arch       Date:  2010-08-24       Impact factor: 3.657

8.  Methamphetamine-like discriminative-stimulus effects of nicotinic agonists.

Authors:  Rajeev I Desai; Jack Bergman
Journal:  J Pharmacol Exp Ther       Date:  2014-01-03       Impact factor: 4.030

9.  Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.

Authors:  C Reavill; J A Waters; I P Stolerman; H S Garcha
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Authors:  Fabio Marti; Ouafa Arib; Carole Morel; Virginie Dufresne; Uwe Maskos; Pierre-Jean Corringer; Renaud de Beaurepaire; Philippe Faure
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.